Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
255.28
-2.66 (-1.03%)
Sep 29, 2026, 1:53 PM EDT - Market open
Tenet Healthcare Stock Forecast
Stock Price Forecast
According to 23 analysts polled by S&P Global, Tenet Healthcare stock has a consensus rating of "Buy" and an average price target of $284.64. The average 1-year stock price forecast is 11.50% higher than the current stock price, while the lowest is $260 (+1.85%) and the highest is $315 (+23.40%).
Price Target: $284.64 (+11.50%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Tenet Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 14 | 14 | 14 | 14 | 14 |
| Buy | 6 | 6 | 6 | 5 | 5 | 5 |
| Hold | 2 | 2 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 22 | 22 | 22 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Reiterates $285 | Buy | Reiterates | $285 | +11.64% | Sep 28, 2026 |
| BMO Capital | BMO Capital | Hold Initiates $265 | Hold | Initiates | $265 | +3.81% | Sep 22, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 18, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $274 | Buy | Maintains | $274 | +7.34% | Sep 14, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $315 | Buy | Maintains | $315 | +23.40% | Sep 2, 2026 |
Financial Forecast
Revenue This Year
22.43B
from 21.31B
Increased by 5.25%
Revenue Next Year
22.52B
from 22.43B
Increased by 0.41%
EPS This Year
21.22
from 16.78
Increased by 26.48%
EPS Next Year
21.08
from 21.22
Decreased by -0.66%
EPS and Forward PE are based on non-GAAP adjusted numbers.